Chinook Therapeutics Inc Cvr (ADRO)
CapEx to Revenue
9.88%
Quarterly · Period ending:
ADRO CapEx to Revenue
Latest reported9.88%period ending
Latest reported9.88%period ending
ADRO Quarterly CapEx/Revenue (504.00% → 9.88%)
Latest values, visible window
High-resolution chart · PNG
ADRO capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 9.8759% | |
| 0% | |
| 0.3441% | |
| 2.1195% | |
| 16.691% | |
| 0% | |
| 10.7669% | |
| 12.9804% | |
| 38.5896% | |
| 0% | |
| 31.9753% | |
| 47.1778% | |
| 50.8434% | |
| 12.0331% | |
| 19.6448% | |
| 113.6668% | |
| 235.7143% | |
| 23.5281% | |
| 33.871% | |
| 1.0414% | |
| 3.4002% | |
| 8.6107% | |
| 3.2797% | |
| 0% | |
| 8.4875% | |
| 14.3147% | |
| 504% |